Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02410577 : 89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
PhaseN/A
AgesMin: 26 Years Max: 79 Years
Eligibility
Inclusion Criteria:

- Patient age > 25 years old and < 80 years old

- Patients with reoccurrence of brain tumor

- The principal investigator or co-PI must review MRI and CT findings based on the
radiologic assessment provided they meet the following imaging criteria (as
established in the clinical trial 09-177):

OR

- Patients with newly diagnosed GBM and one of the following options:

- Eligible for surgery after the last research scan.

- Significant residual disease after initial surgery

- The principal investigator or co-PI must review MRI and CT findings and agree with
the presence of significant residual disease

- Treatment (non-surgical) naïve

- Karnofsky Performance Score ? 70

Exclusion Criteria:

- Laboratory values:

- Serum creatinine >2.5 mg/dL.

- AST (SGOT) >2.5x ULN.

- Bilirubin (total) >1.5x ULN.

- Serum calcium >11 mg/dL.

- Pregnant or breastfeeding (if a female is of childbearing potential, and unsure of
pregnancy status, a standard pregnancy test should be done).

- If an initial biopsy demonstrates neoplasm other than GBM

- Presence of any other co-existing condition which, in the judgment of the
investigator, might increase the risk to the subject.

- Presence of serious systemic illness, including: uncontrolled inter-current
infection, uncontrolled malignancy, significant renal disease, or psychiatric/social
situations, which might limit compliance with study requirements

- Prior treatment.

- Other serious illness (es), which might preclude completion of this, study or
interfere with determination of causality of any adverse effects experienced in this
study.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02410577      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740